| Date Filed | Type | Description |
| 12/30/2019 |
GN
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – INST, THOR, TCBI, ARQL |
| 12/28/2019 |
GN
| THOR, ARQL, TIF, and AMTD SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts |
| 12/12/2019 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of the Following Mergers |
| 12/09/2019 |
GN
| ArQule Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of ArQule, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ARQL |
| 02/26/2019 |
GN
| Factors of Influence in 2019, Key Indicators and Opportunity within Conagra Brands, Pieris Pharmaceuticals, ArQule, MoneyGram International, Internap, and TIM Participacoes S.A — New Research Emphasizes Economic Growth |
| 11/29/2018 |
GN
| Recent Analysis Shows HudBay Minerals, Meridian Bioscience, ArQule, Mesoblast, Concho Resources, and Liberty Global Market Influences — Renewed Outlook, Key Drivers of Growth |
| 06/11/2018 |
GN
| The Race to Treat Cancer, ArQule Inc. Continues Progress Across All Pipeline Assets |
| 06/08/2018 |
GN
| Research Report Identifies Qudian Inc., ICICI Bank, Mobile TeleSystems OJSC, ArQule, Alibaba Group Holding, and Arcos Dorados with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement |
| 05/07/2018 |
BW
| ArQule Reports First Quarter 2018 Financial Results |
| 04/23/2018 |
BW
| ArQule to Report First Quarter 2018 Financial Results on May 7, 2018 |
| 03/27/2018 |
GN
| Recent Analysis Shows Energy Fuels, Vipshop, Tenaris S.A, ArQule, Teekay Offshore Partners, and Chicago Bridge & Iron Company N.V Market Influences — Renewed Outlook, Key Drivers of Growth |
| 03/05/2018 |
BW
| ArQule Reports Fourth Quarter and Full Year 2017 Financial Results |
| 02/20/2018 |
BW
| ArQule To Report Fourth Quarter 2017 Financial Results On March 5, 2018 |
| 11/09/2017 |
BW
| ArQule Reports Third Quarter 2017 Financial Results |
| 10/26/2017 |
BW
| ArQule To Report Third Quarter 2017 Financial Results On November 9, 2017 |
| 09/19/2017 |
BW
| ArQule to Present at the Cantor Fitzgerald Global Healthcare Conference on September 26, 2017 |
| 07/21/2017 |
BW
| ArQule To Report Second Quarter 2017 Financial Results On August 4, 2017 |
| 05/03/2017 |
BW
| Arqule Reports First Quarter 2017 Financial Results |
| 04/19/2017 |
BW
| ArQule To Report First Quarter 2017 Financial Results On May 3, 2017 |
| 03/07/2017 |
BW
| ArQule Reports Fourth Quarter and Full Year 2016 Financial Results |
| 02/24/2017 |
BW
| ArQule To Report Fourth Quarter and Year End 2016 Financial Results On March 7, 2017 |
| 06/05/2012 |
PRN
| Presentati al 48° Congresso ASCO i risultati positivi dello studio di fase II di tivantinib in pazienti con carcinoma epatocellulare già pretrattati |
| 05/05/2011 |
BW
| ArQule Reports First Quarter 2011 Financial Results |
| 04/28/2011 |
BW
| ArQule to Report First Quarter 2011 Financial Results on May 5, 2011 |
| 04/28/2011 |
BW
| ArQule, Inc. Announces Appointment of Dr. Susan Kelley to Board of Directors |
| 04/11/2011 |
BW
| ArQule, Inc. to Present at Future Leaders in the Biotech Industry Conference |
| 03/31/2011 |
BW
| ArQule Announces Presentations at AACR 102nd Annual Meeting |
| 03/30/2011 |
BW
| ArQule, Inc. to Present at Needham and Leerink Swann Conferences |
| 03/01/2011 |
BW
| ArQule Reports Fiscal 2010 Year End and Fourth Quarter Results |
| 02/28/2011 |
BW
| ArQule, Inc. Announces Departure of Board Member |
| 02/23/2011 |
BW
| ArQule, Inc. to Present at Citi and Cowen Investment Conferences |
| 02/22/2011 |
BW
| ArQule to Report Fiscal 2010 Financial Results on March 1, 2011 |
| 12/06/2010 |
BW
| ArQule Enrolls First Patient in Phase 1 Trial of ARQ 736, Its Pan-RAF Inhibitor |
| 11/10/2010 |
BW
| ArQule, Inc. to Present at Lazard Capital Markets 7th Annual Healthcare Conference |
|